Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

- September 15th, 2020

Oakville, Ontario– – Cardiol Therapeutics Inc. a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including heart failure and acute myocarditis, announces that Cardiol’s President and CEO, Mr. David Elsley, will present a company overview at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference today at 12:00 PM EDT. A live webcast …

Oakville, Ontario–(Newsfile Corp. – September 15, 2020) – Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX:CRTPF) (“Cardiol” or the “Company”), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including heart failure and acute myocarditis, announces that Cardiol’s President and CEO, Mr. David Elsley, will present a company overview at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference today at 12:00 PM EDT. A live webcast and replay of the presentation will be accessible on the Company’s website section https://www.cardiolrx.com/investors/events-presentations/ About Cardiol Therapeutics Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX:CRTPF) (“Cardiol” or the “Company”) is a leader …

Get the latest marijuana stock news, cannabis on stock news on PotStockNews

All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.

News Provided by Pot Stock News via QuoteMedia

Leave a Reply